|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00000596 |
|
Date of registration:
|
27/10/1999 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Diffuse Fibrotic Lung Disease
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
June 1978 |
|
Target sample size:
|
|
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00000596 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Primary Purpose: Treatment
|
|
Phase:
|
Phase 2
|
|
|
Key inclusion & exclusion criteria
|
No eligibility criteria
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Sarcoidosis
|
|
Lung Diseases
|
|
Pulmonary Fibrosis
|
|
Intervention(s)
|
|
Drug: prednisone
|
|
Drug: cyclophosphamide
|
|
Drug: dapsone
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|